Efficacy and safety of ophthalmic epinastine evaluated using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis

被引：0

作者：

Schiffman, RM

Abelson, MB

Crampton, HJ

Slugg, AP

Michaelson, C

Bradford, RR

Kim, B

Lue, JC

Whitcup, SM

机构：

[1] Allergan Pharmaceut Inc, Irvine, CA USA

[2] Schepens Eye Res Inst, Boston, MA USA

[3] Ophthalm Res Associates, N Andover, MA USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

107

引用

页码：U17 / U17

页数：1

共 50 条

[1] Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis
Abelson, MB
Gomes, P
Crampton, HJ
Schiffman, RM
Bradford, RR
Whitcup, SM
CLINICAL THERAPEUTICS, 2004, 26 (01) : 35 - 47
[2] Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis
Tagawa, Yoshiaki
Namba, Kenichi
Nakazono, Yumi
Iwata, Daiju
Ishida, Susumu
ALLERGOLOGY INTERNATIONAL, 2017, 66 (02) : 338 - 343
[3] Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge
Fujishima, Hiroshi
Ohashi, Yuichi
Takamura, Etsuko
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (04) : 476 - 481
[4] Efficacy and safety of ophthalmic epinastine for treatment of seasonal allergic conjunctivitis
Whitcup, SM
Abelson, M
Slugg, A
Gomes, P
Bradford, R
Lue, J
Kim, B
Schiffman, R
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U310 - U310
[5] Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis
Greiner, JV
Mundorf, T
Dubiner, H
Lonsdale, J
Casey, R
Parver, L
Kapik, BM
Shams, NBK
Abelson, MB
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (06) : 1097 - 1105
[6] Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model
Torkildsen, Gail
Narvekar, Abhijit
Bergmann, Mark
CLINICAL OPHTHALMOLOGY, 2015, 9 : 1703 - 1713
[7] Clinical efficacy of olopatadine and epinastine in allergic conjunctivitis subjects defined by sensitivity to conjunctival allergen challenge (CAC)
D'Arienzo, PA
Granet, D
Epstein, AB
Lanier, BQ
Finegold, I
Ledgerwood, GL
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
[8] Efficacy and Safety Of a New Olopatadine Hydrochloride, 0.77% Ophthalmic Formulation In Patients With Allergic Conjunctivitis Using The Conjunctival Allergen Challenge (CAC) Model (NCT01479374)
Torkildsen, Gail
Macejko, Thomas
Narvekar, Abhijit
Bergmann, Mark
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB277 - AB277
[9] Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model
Lanier, BQ
Finegold, I
D'Arienzo, P
Granet, D
Epstein, AB
Ledgerwood, GL
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (08) : 1227 - 1233
[10] Efficacy of epinastine HCl 0.05% ophthalmic solution in patients with acute allergic conjunctivitis compared with ketotifen
Bonini, S
Whitcup, SM
Barrett, J
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U530 - U530

← 1 2 3 4 5 →